| Chlorobionta| Chlorobionta Bremer, 1985| Chlorophyta/Embryophyta group| chlorophyte/embryophyte group| green plants| Viridiplantae| Viridiplantae Cavalier-Smith, 1981
Oxygen Production: One of the significant contributions of Viridiplantae to human health is their role in oxygen production through photosynthesis. During this process, green plants take in carbon dioxide and release oxygen, helping to maintain the atmospheric balance of gases necessary for human and animal respiration.
Food Source: Many plants within the kingdom Viridiplantae are sources of food for humans and animals. Fruits, vegetables, grains, and other plant-based foods contribute essential nutrients to human diets.
Medicinal Plants: Some plants within Viridiplantae have medicinal properties and are used in traditional and modern medicine. Many pharmaceutical drugs are derived from plant compounds, and herbal remedies are employed for various health purposes.
Environmental Impact: Green plants play a crucial role in ecosystems by contributing to soil stability, preventing erosion, and influencing climate patterns. Forests, grasslands, and other plant-dominated environments provide habitats for diverse organisms and contribute to overall environmental health.
Aesthetic and Recreational Value: Green plants contribute to the aesthetic beauty of landscapes, gardens, and natural environments. Access to green spaces has been associated with psychological well-being, and recreational activities in natural settings offer health benefits.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 1.06 | 6 | 316300 | 0 | 139875 | 13432.8 | 120 | 64511.2 | 0 | 620 | 0 %ile | 100 %ile | ||
biomesight | 23.13 | 0 | 10 | 10 | 190 | 0 | 3364 | 140.8 | 30 | 1644.5 | 10 | 70 | 0 %ile | 95.3 %ile |
thryve | 0.99 | 10 | 138 | 0 | 118 | 44.2 | 31 | 37.8 | 10 | 138 | 7.7 %ile | 84.6 %ile | ||
ubiome | 2.28 | 22 | 557 | 0 | 424 | 124.9 | 52 | 152.4 | 22 | 557 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 6.667 % | 0.01 % | % | 1.0 | 15 |
BiomeSight | 24.081 % | 0.014 % | 0.148 % | 714.0 | 2965 |
BiomeSightRdp | 80.645 % | 0.019 % | 0.026 % | 25.0 | 31 |
es-xenogene | 6.897 % | 15.816 % | 22.364 % | 2.0 | 29 |
Medivere | 42.857 % | 0.003 % | 0.002 % | 3.0 | 7 |
SequentiaBiotech | 5.556 % | 0.075 % | 0.063 % | 2.0 | 36 |
Thorne | 14.423 % | 0 % | 0 % | 15.0 | 104 |
Thryve | 0.79 % | 0.004 % | 0.004 % | 11.0 | 1392 |
uBiome | 2.273 % | 0.012 % | 0.015 % | 18.0 | 792 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.